SKVI
SKINVISIBLE INC
stockOTC
skinvisible, inc., through its wholly owned subsidiary, skinvisible pharmaceuticals, inc., is an r&d pharmaceutical company that develops enhanced, patented dermatology and healthcare products to treat skin conditions from acne to warts, along with sunscreens, anti-aging products, hand sanitizing lotions, pre-surgical preparations, and medical treatments outside of dermatology using its patented technology invisicare®. skinvisible's primary objective is to license these prescription and over-the-counter products into the global dermatology and medical markets. potential licensees include international and multi-national pharmaceutical, cosmetic, skincare and consumer goods companies seeking new products or life cycle management for their existing products. www.invisicare.com and www.skinvisible.com
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1M | 0.20 | 2026-09-04 | +0.55% | -0.975 |
| 3M | 0.22 | 2026-07-07 | -8.14% | -4.493 |
| 6M | 0.32 | 2026-04-07 | -36.84% | -2.054 |
| 1Y | 0.14 | 2025-10-07 | +41.33% | 10.927 |
| 2Y | 0.57 | 2024-10-08 | -64.30% | — |
| 5Y | 0.11 | 2021-10-05 | +83.73% | -0.157 |
SKINVISIBLE INC (OTC:SKVI) stock price today is $0.20, and today's volume is 260. SKVI is up 0.000% today. The 30 day average volume is 2,793. SKVI market cap is $988,237 with 4.89M shares outstanding.